Puma Biotechnology's chart data is dated 2026-10-09. Recorded technical signals: 52-week high, MA aligned, VCP, MACD bullish cross. There are 15 published signal records.
Puma Biotechnology last closed at $10.29 (+3.21%) on 2026-10-09. Signals today: 52-week high, MA aligned, VCP, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 19.6×. Its overall grade ranks 95 of 738 stocks in Healthcare.
About this company
Puma Biotechnology last closed at $10.29 (+3.21%) on 2026-10-09. Signals today: 52-week high, MA aligned, VCP, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 95/738
Valuation grade F
Related stocks
- PfizerCompetitor
HER2 양성 유방암 치료제 시장에서 경쟁
- RocheCompetitor
HER2 표적항암제 계열의 주요 경쟁사
- EisaiCompetitor
암 치료제 포트폴리오에서 간접 경쟁
About Puma Biotechnology
- What technical signals does Puma Biotechnology (PBYI) have?
- Puma Biotechnology current technical signals: MA alignment (score 0.71).
- Is Puma Biotechnology a cup-and-handle pattern?
- No. Puma Biotechnology has no valid Cup signal right now.
- What published figures are available for Puma Biotechnology?
- Market cap: $518.52M. Trailing 12 months PER: 19.6×. Latest quarter PBR: 3.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Puma Biotechnology, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.